User profiles for Craig D. Shriver
Craig ShriverUniformed Services University of the Health Sciences Verified email at usuhs.edu Cited by 43092 |
[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …
[PDF][PDF] Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients
…, CE Storrer, C Fisher, CD Shriver… - Journal of Clinical …, 2005 - researchgate.net
Purpose E75 is an immunogenic peptide from the HER2/neu protein that is highly
expressed in breast cancer. We are conducting a clinical trial of an E75 granulocyte-macrophage …
expressed in breast cancer. We are conducting a clinical trial of an E75 granulocyte-macrophage …
Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas
Importance African Americans have the highest breast cancer mortality rate. Although racial
difference in the distribution of intrinsic subtypes of breast cancer is known, it is unclear if …
difference in the distribution of intrinsic subtypes of breast cancer is known, it is unclear if …
[HTML][HTML] Molecular heterogeneity in breast cancer: State of the science and implications for patient care
RE Ellsworth, HL Blackburn, CD Shriver… - Seminars in cell & …, 2017 - Elsevier
The identification of extensive genetic heterogeneity in human breast carcinomas poses a
significant challenge for designing effective treatment regimens. Significant genomic evolution …
significant challenge for designing effective treatment regimens. Significant genomic evolution …
Assessing semantic similarity measures for the characterization of human regulatory pathways
Motivation: Pathway modeling requires the integration of multiple data including prior
knowledge. In this study, we quantitatively assess the application of Gene Ontology (GO)-derived …
knowledge. In this study, we quantitatively assess the application of Gene Ontology (GO)-derived …
Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories
…, RM Jordan, SJ Russell, CD Shriver - … journal of cancer, 2006 - Wiley Online Library
Matrix metalloproteinase (MMP) 2 and 9 are involved in cancer invasion and metastasis, and
increased levels occur in serum and plasma of breast cancer (BC) patients. It is, however, …
increased levels occur in serum and plasma of breast cancer (BC) patients. It is, however, …
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype
…, R van Laar, C Gallagher, CD Shriver… - Annals of surgical …, 2013 - Springer
Background Determination of estrogen receptor (ER), progesterone receptor (PR), and human
epidermal growth factor receptor 2 (HER2) status is standard for predicting prognosis and …
epidermal growth factor receptor 2 (HER2) status is standard for predicting prognosis and …
The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy
…, PC Melder, R Langley, V Bernet, CD Shriver - Thyroid, 2006 - liebertpub.com
Purpose: To evaluate the rapid parathyroid hormone assay (rPTH) as a perioperative tool in
predicting postoperative symptomatic hypocalcemia following thyroidectomy. Methods: We …
predicting postoperative symptomatic hypocalcemia following thyroidectomy. Methods: We …
[HTML][HTML] Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African …
LA Sturtz, J Melley, K Mamula, CD Shriver… - BMC cancer, 2014 - Springer
Background Although diagnosed less often, breast cancer in African American women (AAW)
displays different characteristics compared to breast cancer in Caucasian women (CW), …
displays different characteristics compared to breast cancer in Caucasian women (CW), …
Factors associated with survival disparities between non-Hispanic Black and White patients with uterine cancer
…, TD O'Connor, JH Farley, CD Shriver… - JAMA network …, 2023 - jamanetwork.com
Importance Disparities in survival exist between non-Hispanic Black (hereafter, Black) and
non-Hispanic White (hereafter, White) patients with uterine cancer. Objective To investigate …
non-Hispanic White (hereafter, White) patients with uterine cancer. Objective To investigate …